- Novel Coronavirus
-
Drug Discovery Services
- Antiviral Drug Discovery
- Complement Therapy
- SARS-CoV-2 Aptamers
- Antisense Oligonucleotides
- Protease Inhibitors
- Inhibitor of Host Cell Protease
- Abelson Kinase Inhibitors
- RNA Synthesis Inhibitors
- Nucleoside Analogue
- Neuraminidase Inhibitors
- Neutralizing Antibody
- Antiviral Peptide
- Broad-spectrum Antiviral Drug
- Anti-Inflammatory Drugs
- High-Throughput Screening
- Vaccine Discovery
- Evaluation Platforms for SARS-CoV-2 Drugs
- Antiviral Drug Discovery
- IVD Immunoassays
- Products
- Resources
- About Us
Losartan potassium (CAT#: Vinh-004SX)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| Vinh-004SX |
|
For Research Use Only. We do not provide direct services or products for patients.
- Product Overview
- 2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl]methyl}-1H-imidazole-5-methanol, potassium salt (DUP-753), Angiotensin II Receptor Antagonist
- Target
- SARS-CoV-2
- Molecular Formula
- C22H22ClN6O·K
- Molecular Weight
- 461.0 g/mol
- Purity
- >99% by HPLC
- Storage
- Store at 4°C.
- Introduction
- Losartan potassium is an active, nonpeptide angiotensin II (AII) receptor antagonist, and has high affinity and selectivity against to the AII subtype 1 receptor. it is currently being used as a treatment option against hypertension. SARS-CoV-2 infects the human cells by its Spike (S) protein binding to the human ACE2 cell receptor. Renin-Angiotensin-Aldosterone System Inhibitors such losartan are being investigated for their unconventional role in inhibiting SARS-CoV-2/ACE2 fusions at the moment as a possible treatment option to solve the COVID-19 crisis.
Online Inquiry
For Research Use Only. We do not provide direct services or products for patients.
For Research Use Only. We do not provide direct services or products for patients.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.